As of 2025-06-21, the Fair Value of MEI Pharma Inc (MEIP) is -23.77 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.20 USD, the upside of MEI Pharma Inc is -1,180.50%.
With the market price of 2.20 USD and our fair value calculation, MEI Pharma Inc (MEIP) is not a good investment. Investing in MEIP stocks now will result in a potential loss of 1,180.50%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 5Y Avg | |
| Net income | -47.17 | -41.31 | -54.45 | -31.84 | 17.78 | -31.40 |
| YoY growth | -180.44% | 12.42% | -31.81% | 41.52% | 155.84% | -0.49% |
| Market Cap (mil) | 14.65 |
| P/E | |
| Forward P/E | 1.08x |
| EPS | -4.75 |
| Avg earnings growth rate | -0.49% |
| TTM earnings | -31.66 |